HMN 2025: How New opioid testing strategies might result in higher therapies

New opioid testing techniques could lead to better therapies
With an eye fixed towards enhancing care, researchers have developed new automated lab procedures for detecting opioids in tiny quantities of blood. Credit: Tripathi Lab/Brown University

As the opioid epidemic persists throughout the United States, a crew of researchers from Brown University has developed new diagnostic strategies for detecting opioid compounds in adults with opioid use dysfunction and infants with neonatal abstinence syndrome.

The new strategies, described in two lately printed analysis research, might equip with highly effective new instruments for extra successfully treating circumstances associated to opioid publicity, the researchers say.

In a research printed in Scientific Reports, the researchers describe a technique that may quickly detect six totally different opioid compounds from a tiny quantity of serum—not more than a finger prick.

The second study, published in SLAS Technology, demonstrates a technique for detecting opioids in dried blood spots, that are routinely collected from newborns nationwide. The method might allow a first-of-its-kind quantitative methodology for assessing opioid publicity in newborns.

The analysis was led by Ramisa Fariha, a postdoctoral analysis affiliate in , and biochemistry at Brown who carried out the work whereas finishing her Ph.D. in Brown’s School of Engineering. The work was a collaboration with Carolina Haass-Koffler, an affiliate professor at Brown’s School of Public Health.

“This undertaking is an instance of what occurs when translational engineering meets public well being,” mentioned Anubhav Tripathi, a professor in Brown’s School of Engineering who oversaw the work.

“Dr. Haass-Koffler approached us with a problem: How can we allow extra dependable testing of opioid publicity? Ramisa was capable of take up that problem and develop one thing fairly outstanding within the lab.”

Fariha hopes the work will spur real-world functions in opioid remedy.

“This wasn’t about creating one other lab software,” she mentioned. “It was about reimagining what’s potential on the mark of care. We had been responding to a void that was all the time there, and we needed to deal with it.”

Adults with opioid use dysfunction

The work started with Haass-Koffler speaking with members of the engineering crew in regards to the challenges in measuring the presence of opioid substances in individuals with .

Blood testing for opioids typically requires substantial portions of blood, which may be tough to get from frequent opioid customers who could have collapsed veins or different circumstances. Urine exams, however, ceaselessly produce inaccurate outcomes.

Working intently with John Murphy, a analysis engineer at Brown, Fariha developed a completely automated liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay to detect opioid compounds from microsamples together with serum or blood spots.

New opioid testing techniques could lead to better therapies
A schematic of the pattern preparation workflow for conventional methodology (30 min) towards the proposed methodology (3 min); (B) A magnified illustration of the DBS milieu within the cylindrical electrode system properly. Credit: SLAS Technology (2025). DOI: 10.1016/j.slast.2025.100282

They confirmed that the system is able to precisely quantifying six totally different opioids—together with buprenorphine, methadone, codeine, hydrocodone, morphine and oxycodone—utilizing a small pattern of simply 20 microliters (lower than a single drop) of serum.

Haass-Koffler then built-in the brand new diagnostic method into an ongoing medical trial. The trial, which assesses using oxytocin as a complement to opioid agonist remedy, leveraged the microsampling methodology to detect opioid use that conventional urine samples had missed.

This enhanced detection functionality offered important insights, serving to the analysis crew reveal that administering oxytocin could be a beneficial software in decreasing opioid use amongst individuals with opioid use dysfunction.

Detecting opioids in newborns

After creating a technique for detecting opioids from small blood samples in adults, the researchers started considering of different methods to use it. Neonatal abstinence syndrome (NAS), wherein infants are born with signs of opioid withdrawal, appeared like an apparent selection, they mentioned.

Opioid use amongst is alarmingly excessive within the U.S. One current study by the Centers for Disease Control and Prevention discovered that one in 5 pregnant ladies self-reported opioid misuse. Diagnosis of opioid publicity in newborns is at the moment made by assessing a child’s signs and reviewing a mom’s opioid use historical past. There is at the moment no commonplace blood check for opioids in infants.

“The concept behind this work was to give you a diagnostic methodology that is extra quantitative,” Fariha mentioned.

The answer was a tool that may extract potential opioid samples from dried , that are routinely gathered shortly after beginning from a small prick on a child’s heel. The system applies an electrical area to a dried blood spot to attract up potential opioid compounds. Once the pattern is ready, it may be despatched to a lab for evaluation with a mass spectrometer, which is usually utilized in neonatal testing.

The analysis confirmed that the method can efficiently detect a spread of opioid substances, together with codeine, hydrocodone, morphine, methadone and oxycodone. And the method is absolutely automated, making it simple to deploy on the medical stage, the researchers say.

Fariha mentioned she’s hopeful that the method cannot solely enhance analysis of NAS, but additionally remedy. If clinicians know exactly how a lot opioid is current, they may doubtlessly make extra knowledgeable choices about whether or not medicine is important and in what quantities.

“At its core, this work is about greater than automation,” Fariha mentioned. “It’s about designing diagnostic instruments which can be exact, scalable and higher aligned with the wants of real-world sufferers, particularly in maternal and toddler well being.”

The researchers say each research characterize an effort to make diagnostics extra helpful, accessible and patient-centered.

“Diagnostics should not be locked inside centralized labs,” Fariha mentioned.

“I need to design methods that meet sufferers where they’re—whether or not that is a new child in a NICU or a village clinic midway world wide. As a Bangladeshi girl, I acknowledge the necessity for options with world translatability and impression, with out requiring main infrastructural help.”

More info:
Ramisa Fariha et al, Opioid quantification by way of microsampling strategies to evaluate opioid use in human laboratory research, Scientific Reports (2025). DOI: 10.1038/s41598-025-99130-5

Ramisa Fariha et al, Precision by way of electric-field assisted automatable excessive throughput pattern preparation of dried blood spots for neonatal abstinence syndrome detection, SLAS Technology (2025). DOI: 10.1016/j.slast.2025.100282

Provided by
Brown University


Citation:
New opioid testing strategies might result in higher therapies ( 16)
19
opioid-techniques-therapies.html

.
. The content material is offered for info functions solely.